US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.7030
  • -0.0070-0.99%
Close Jun 4 16:00 ET
  • 0.7045
  • +0.0015+0.21%
Post 19:34 ET
1.48MMarket Cap-48P/E (TTM)

Virpax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
-48.44%19M
-50.71%20.56M
148.99%26.06M
-Cash and cash equivalents
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
-48.44%19M
-50.71%20.56M
148.99%26.06M
Prepaid assets
26.83%1.18M
-35.74%419.61K
-35.74%419.61K
78.20%855.28K
45.45%1.1M
-19.13%932.69K
155.24%653.02K
155.24%653.02K
4.56%479.97K
-17.19%757.86K
Other current assets
-85.83%81.31K
165.27%67.22K
165.27%67.22K
-98.84%30.11K
-98.26%45.08K
-79.48%573.74K
-98.98%25.34K
-98.98%25.34K
135.62%2.59M
44,978.52%2.58M
Total current assets
-83.07%3.13M
-51.06%9.63M
-51.06%9.63M
-44.84%13.04M
-45.75%15.95M
-46.78%18.49M
-50.28%19.67M
-50.28%19.67M
-45.38%23.64M
158.19%29.4M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-83.07%3.13M
-51.06%9.63M
-51.06%9.63M
-44.84%13.04M
-45.75%15.95M
-46.78%18.49M
-50.28%19.67M
-50.28%19.67M
-45.38%23.64M
158.19%29.4M
Liabilities
Current liabilities
Payables
-70.66%13.28K
-50.97%18.46K
-50.97%18.46K
131.77%33.19K
169.35%76.06K
335.06%45.25K
89.73%37.64K
89.73%37.64K
2,408.06%14.32K
-61.94%28.24K
-Total tax payable
----
----
----
----
----
----
----
----
--0
-20.00%8K
-Other payable
-70.66%13.28K
-50.97%18.46K
-50.97%18.46K
131.77%33.19K
275.82%76.06K
335.06%45.25K
89.73%37.64K
89.73%37.64K
2,408.06%14.32K
-68.47%20.24K
Current accrued expenses
46.56%1.83M
58.53%1.68M
58.53%1.68M
-65.64%1.44M
-45.55%1.34M
-42.61%1.25M
-48.89%1.06M
-48.89%1.06M
140.82%4.19M
50.38%2.46M
Other current liabilities
25.00%2.5M
200.00%6M
200.00%6M
--5M
--2M
--2M
--2M
--2M
----
----
Current liabilities
31.86%4.34M
148.63%7.69M
148.63%7.69M
55.25%6.53M
46.85%3.65M
50.64%3.29M
48.23%3.09M
48.23%3.09M
132.25%4.21M
-12.26%2.48M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
31.86%4.34M
148.63%7.69M
148.63%7.69M
55.25%6.53M
46.85%3.65M
50.64%3.29M
48.23%3.09M
48.23%3.09M
132.25%4.21M
-35.53%2.48M
Shareholders'equity
Share capital
-89.74%12
0.00%12
0.00%12
0.00%117
0.00%117
0.00%117
-89.74%12
-89.74%12
0.00%117
134.00%117
-common stock
-89.74%12
0.00%12
0.00%12
0.00%117
0.00%117
0.00%117
-89.74%12
-89.74%12
0.00%117
134.00%117
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-36.82%-62.76M
-34.25%-59.54M
-34.25%-59.54M
-32.91%-54.98M
-45.25%-48.99M
-64.78%-45.88M
-95.36%-44.35M
-95.36%-44.35M
-122.57%-41.37M
-119.42%-33.73M
Paid-in capital
0.78%61.55M
0.89%61.48M
0.89%61.48M
1.14%61.49M
1.07%61.29M
1.12%61.07M
1.24%60.93M
1.24%60.93M
1.25%60.8M
164.75%60.64M
Total stockholders'equity
-107.98%-1.21M
-88.33%1.93M
-88.33%1.93M
-66.51%6.51M
-54.29%12.3M
-53.32%15.2M
-55.77%16.58M
-55.77%16.58M
-53.14%19.43M
257.22%26.92M
Total equity
-107.98%-1.21M
-88.33%1.93M
-88.33%1.93M
-66.51%6.51M
-54.29%12.3M
-53.32%15.2M
-55.77%16.58M
-55.77%16.58M
-53.14%19.43M
257.22%26.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M-48.44%19M-50.71%20.56M148.99%26.06M
-Cash and cash equivalents -89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M-48.44%19M-50.71%20.56M148.99%26.06M
Prepaid assets 26.83%1.18M-35.74%419.61K-35.74%419.61K78.20%855.28K45.45%1.1M-19.13%932.69K155.24%653.02K155.24%653.02K4.56%479.97K-17.19%757.86K
Other current assets -85.83%81.31K165.27%67.22K165.27%67.22K-98.84%30.11K-98.26%45.08K-79.48%573.74K-98.98%25.34K-98.98%25.34K135.62%2.59M44,978.52%2.58M
Total current assets -83.07%3.13M-51.06%9.63M-51.06%9.63M-44.84%13.04M-45.75%15.95M-46.78%18.49M-50.28%19.67M-50.28%19.67M-45.38%23.64M158.19%29.4M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -83.07%3.13M-51.06%9.63M-51.06%9.63M-44.84%13.04M-45.75%15.95M-46.78%18.49M-50.28%19.67M-50.28%19.67M-45.38%23.64M158.19%29.4M
Liabilities
Current liabilities
Payables -70.66%13.28K-50.97%18.46K-50.97%18.46K131.77%33.19K169.35%76.06K335.06%45.25K89.73%37.64K89.73%37.64K2,408.06%14.32K-61.94%28.24K
-Total tax payable ----------------------------------0-20.00%8K
-Other payable -70.66%13.28K-50.97%18.46K-50.97%18.46K131.77%33.19K275.82%76.06K335.06%45.25K89.73%37.64K89.73%37.64K2,408.06%14.32K-68.47%20.24K
Current accrued expenses 46.56%1.83M58.53%1.68M58.53%1.68M-65.64%1.44M-45.55%1.34M-42.61%1.25M-48.89%1.06M-48.89%1.06M140.82%4.19M50.38%2.46M
Other current liabilities 25.00%2.5M200.00%6M200.00%6M--5M--2M--2M--2M--2M--------
Current liabilities 31.86%4.34M148.63%7.69M148.63%7.69M55.25%6.53M46.85%3.65M50.64%3.29M48.23%3.09M48.23%3.09M132.25%4.21M-12.26%2.48M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 31.86%4.34M148.63%7.69M148.63%7.69M55.25%6.53M46.85%3.65M50.64%3.29M48.23%3.09M48.23%3.09M132.25%4.21M-35.53%2.48M
Shareholders'equity
Share capital -89.74%120.00%120.00%120.00%1170.00%1170.00%117-89.74%12-89.74%120.00%117134.00%117
-common stock -89.74%120.00%120.00%120.00%1170.00%1170.00%117-89.74%12-89.74%120.00%117134.00%117
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -36.82%-62.76M-34.25%-59.54M-34.25%-59.54M-32.91%-54.98M-45.25%-48.99M-64.78%-45.88M-95.36%-44.35M-95.36%-44.35M-122.57%-41.37M-119.42%-33.73M
Paid-in capital 0.78%61.55M0.89%61.48M0.89%61.48M1.14%61.49M1.07%61.29M1.12%61.07M1.24%60.93M1.24%60.93M1.25%60.8M164.75%60.64M
Total stockholders'equity -107.98%-1.21M-88.33%1.93M-88.33%1.93M-66.51%6.51M-54.29%12.3M-53.32%15.2M-55.77%16.58M-55.77%16.58M-53.14%19.43M257.22%26.92M
Total equity -107.98%-1.21M-88.33%1.93M-88.33%1.93M-66.51%6.51M-54.29%12.3M-53.32%15.2M-55.77%16.58M-55.77%16.58M-53.14%19.43M257.22%26.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg